Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc/ US8835561023 /
TMO
2024-03-28 9:10:00 PM
|
Chg.
+1.84
|
Volume |
Bid1:00:00 AM |
Ask1:00:00 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
581.21USD
|
+0.32%
|
1.08 mill. Turnover: 322.19 mill. |
563.94Bid Size: 100 |
595.24Ask Size: 100 |
221.62 bill.USD |
0.24% |
37.45 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
15.52 USD |
-12.56% |
EPS Diluted: |
15.45 USD |
-12.37% |
Revenues per Share: |
112.39 USD |
-3.55% |
Book Value per Share: |
122.53 USD |
7.26% |
Cash Flow per Share: |
22.04 USD |
-7.18% |
Dividend per Share: |
1.40 USD |
16.67% |
Total |
in mill. |
|
Revenues: |
42,857.00 USD |
-4.58% |
Net Income: |
5,995.00 USD |
-13.74% |
Operating Cash Flow: |
8,406.00 USD |
- |
Cash and Cash Equivalents: |
8,077.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
37.45 |
34.20 |
P/S Ratio: |
5.17 |
4.72 |
P/BV ratio: |
4.74 |
4.33 |
P/CF Ratio: |
26.36 |
24.08 |
PEG: |
-2.98 |
-2.72 |
Earnings Yield: |
2.67% |
2.92% |
Dividend Yield: |
0.24% |
0.26% |
Market Capitalization |
|
Market Capitalization: |
221.62 bill. USD |
202.4 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
381.31 mill. |
|
Profitability
Gross Profit Margin: |
- |
EBIT Margin: |
16.00% |
Net Profit Margin: |
13.99% |
Return on Equity: |
12.83% |
Return on Assets: |
6.07% |
Financial Strength
Liquidity I / Cash Ratio: |
57.64% |
Liquidity II / Quick Ratio: |
116.31% |
Liquidity III / Current Ratio: |
175.49% |
Debt / Equity Ratio: |
111.30% |
Dynam. Debt / Equity Ratio: |
618.63% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
US GAAP |